Cystic fibrosis: FAQs on the disease of '65 roses' CBC.ca, Canada - Nov 27, 2008 Cystic fibrosis, or CF, is sometimes called 65 roses. The name came about after a boy overheard his mother talking about the condition on the phone and ...
Cystic Fibrosis Canada.com, Canada - Nov 26, 2008 Cystic fibrosis (CF) is an inherited (genetic) disease in which excess mucus clogs the lungs, prevents food from being digested, and damages the ...
New Drug Bypasses Gene Mutations MIT Technology Review, MA - Nov 13, 2008 The drug has shown promise as a treatment for cystic fibrosis and muscular dystrophy, and it is now being tested in large, international clinical trials. ...
Our Opinion: Walk to beat heart disease, cystic fibrosis Valdosta Daily Times, GA - Nov 5, 2008 In people with Cystic Fibrosis, a defective gene and its protein product cause the body to produce unusually thick, sticky mucus that clogs the lungs and ...
Pulmonary Bacterial Pathogens in Cystic Fibrosis Patients and ... 7thSpace Interactive (press release), NY - Nov 7, 2008 ... Cl- transport by mutations in the CF gene on chromosome 7, which codes for the cystic fibrosis transmembrane conductance regulator protein (CFTR). ...
Simple no-risk prenatal blood test may detect vast range of ... Scientific American - Nov 25, 2008 ... The range of single-gene disorders is vast, from cystic fibrosis to sickle-cell anemia (a disease in which abnormal amounts of iron-rich protein or ...
Ceregene therapy for Parkinson's fails Phase 2 trial San Diego Union Tribune, CA - Nov 27, 2008 Ceregene is also developing therapies for cystic fibrosis and Alzheimer's disease with funding from nonprofit foundations. The company had been developing ...
Nanosphere, Inc. Q3 2008 Earnings Call Transcript Seeking Alpha, NY - Nov 10, 2008 In the Human Genetics market segment, we have filed a 510(k) submission with the FDA for our cystic fibrosis assay comprising the panel of mutations ...NSPH
Source: Google News
Recent News and Articles on the Keywords: 0.21 + protein + pseudomonas Related to the article below (Last Update: 8/7/2008)
Low-Carbodhydrate Digestible Hydrocolloidal Fiber Compositions FLEXNEWS, France - Jul 9, 2008 The method of claim 8, wherein said separating in step (b) is conducted by wet filtration using a screen pore opening in the range of 0.21-0.025 mm and a ...
Guava leaf: A good anti-diarrhoea agent The New Nation, Bangladesh - Jul 26, 2008 ... 76; protein, 1.4; fat, 1.1; carbohydrate, 15.2 grms.; calcium, 20; iron, 1.4; vitamin B-1, 0.21: vitamin B-2, 0.09; and vitamin C 210 mg and carotene, ...
Hypertensive Disorders of Pregnancy RedOrbit, TX - Jul 15, 2008 7 A random urine protein/creatinine ratio of less than 0.21 indicates that significant proteinuria is unlikely with a negative predictive value of 83 ...
Attractive Forces Between Cation Condensed DNA Double Helices RedOrbit, TX - Jul 29, 2008 The general strategy should be useful with other complexes, for instance, in determining the interactions that lead to pathogenic protein aggregation. ...
Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B ?- … - S Minami, H Akama, Y Watanabe, H Narita, S Iyobe, … - Journal of Antimicrobial Chemotherapy, 1996 - Br Soc Antimicrob Chemo ... 0.28 0.23 0.16 0.49 0.210.21 0.18 0.22 0.21 0.51 <0.01 a I 0B ?Bo IPM. Imipenem;
CAZ. ... Cloning of the protein D2 gene of Pseudomonas aeruginosa and its ...
Cystic fibrosis: Hcp1 protein could promote survival of Pseudomonas aeruginosa in lungs
Researchers at Harvard Medical School have discovered one way that a hardy disease-causing bacteria could be surviving in the lungs of chronically infected cystic fibrosis patients.
" This work is important because pathogenic bacteria such as Pseudomonas aeruginosa use protein secretion systems to cause disease in their hosts," said Joseph Mougous, lead author of the study published in the Science. " In the case of Pseudomonas aeruginosa, the host may be a cancer patient with a weakened immune system, a burn patient, or a person with cystic fibrosis."
Pseudomonas aeruginosa, a pathogen that infects more than 80 percent of cystic fibrosis patients, is a leading cause of these patients' death.
Pseudomonas aeruginosa is difficult to treat because it is resistant to many drugs.
" Since we know so little about what this bacterium is up to while it's engaged in these chronic infections, the discovery of this protein secretion system might lead to finding a new target for treatments," said Mougous, at Harvard Medical School.
Researchers at Argonne National Laboratory ( ANL ) provided one of the clues that contributed to the discovery. Working through a number of pathogenic proteins, Marianne Cuff saw a bagel-shaped pore that might be involved in transferring toxins into cells. She deposited the structure of the protein, called Hcp1, into the Protein Data Bank.
While exploring the Protein Data Bank, Mougous recognized that the amino acid sequence of Hcp1 in Pseudomonas aeruginosa closely resembled that of Hcp1 in Vibrio cholerae.
The Mekalanos lab had previously discovered that the Hcp1 protein of Vibrio cholerae is released from the bacterium via a novel secretion pathway. Because Hcp1 proteins from both pathogens belong to the same protein family, Mougous wondered whether the Pseudomonas Hcp1 might also be secreted via this pathway.
The Harvard and Argonne researchers quickly formed a collaboration and confirmed the hypothesis. They then turned their attention to Hcp1 in cystic fibrosis patients to gain more insight in the role of Hcp1 during infection.
Working with cystic fibrosis patients at Children's Hospital Boston, the researchers sought and found Hcp1 in the sputum of patients with Pseudomonas aeruginosa. They also found Hcp1 antibodies in the patients' blood – further evidence that Hcp1 plays a critical role in the infection.
" Patients with cystic fibrosis are particularly susceptible to Pseudomonas aeruginosa, " Mougous said. " The bacterium thrives in the excess mucus that accumulates in their lungs. Once a Pseudomonas aeruginosa infection in a cystic fibrosis patient's lung has been established, these bacteria are difficult or impossible to clear, which over many years eventually results in the death of the patient. Our paper provides evidence that the protein secretion system we discovered represents at least one way this bacterium could be promoting its own survival in the lungs of cystic fibrosis patients."
